Huge executive reshuffle at Saniona – firm to stop US activities

Danish biotech company Saniona is making sweeping changes to its leadership and closing all operations in the US.

Photo: Saniona / PR

Saniona, a Danish biotech company that focuses on rare diseases, is making big changes to its leadership team and streamlining its business, a press release from the firm states.

As of April 30, Saniona’s cofounder, Thomas Feldthus, will become CEO of the company, while Anita Milland will become CFO.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs